The Food and Drug Administration cleared a new cancer-fighting drug called Lynparza for prostate cancer treatment.
Senior Fellow at the Cato Institute Dr. Jeffrey Singer joined The National Desk’s Jan Jeffcoat to discuss the issue.
“Abiraterone is a drug that was approved by the FDA to treat very advanced and very difficult cases of prostate cancer,” he said. “Researchers recently found that by adding the steroid prednisone but it increases effectiveness by 76% and the combination is called Lynparza.”in the PROpel trial that enrolled 796 patients with metastatic castration-resistant prostate cancer.
The study concluded that there was a significant improvement in the patients who received Lynparza with abiraterone.“Lynparza has been approved by the FDA to treat breast cancer, certain kinds of breast cancer, but now it's been approved to treat prostate cancer,” Singer said. “Interestingly, and this is not an unusual story, Lynparza was approved to treat prostate cancer months ago in Europe and other countries.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
The Garage Food Hall nominated for USA Today's Best Food HallVoting ends Monday, July 3 and the winners will be announced on Friday, July 14. You can vote once a day, here.
Weiterlesen »
Carnival embarking drug dogs to stop onboard weed useWeed enthusiasts, take note if you’re planning to vacation aboard Carnival Cruise Line anytime soon.
Weiterlesen »
Breakthrough in Glioma Treatment: New Drug Delays Progression of Deadly Brain CancerStudy is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors. A targeted therapy drug called vorasidenib had positive results in delaying progression of a specific form glioma, a slow-growing but deadly brain cancer. In a study of 331 people wit
Weiterlesen »
Oncologist Pleads Guilty to Prescription Drug FraudA board-certified oncologist has pled guilty to using her medical license to purchase cancer medications under the false pretense that they would be used to treat her own patients. Instead, the drug purchases were part of a fraudulent profit-making scheme.
Weiterlesen »
To ease cancer drug shortage, FDA will allow imports from ChinaThe FDA is working with a Chinese drugmaker to import the chemotherapy drug cisplatin, a strategy aimed at ramping up supply amid an ongoing shortage of the drug in the U.S.
Weiterlesen »
Even Mark Cuban Can’t Fix This Broken Drug SystemCoherus BioSciences’ partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.
Weiterlesen »